SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-007379
Filing Date
2019-02-14
Accepted
2019-02-13 19:04:59
Documents
1
Group Members
GARY J. MORGENTHALERGARY R. LITTLEHENRY PLAINJASON LETTMANNMORGENTHALER MANAGEMENT PARTNERS IX, LLCRALPH E. CHRISTOFFERSENREBECCA LYNNROBERT C. BELLAS, JR.ROBERT D. PAVEY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv513490_sc13g.htm SC 13G 144937
  Complete submission text file 0001144204-19-007379.txt   146765
Mailing Address 2710 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025 650-388-7600
MORGENTHALER VENTURE PARTNERS IX LP (Filed by) CIK: 0001439101 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90643 | Film No.: 19599813
SIC: 2834 Pharmaceutical Preparations